1. Алексеев К.В., Тихонова Н.В., Блынская Е.В., Алексеев В.К., Уваров Н.А., Карбушева Е.Ю. Лекарственные формы с модифицированным высвобождением на основе пеллет. // Фармация. 2012. №4. С. 51-54., Alekseev KV, Tikhonova NV, Blynskaya EV, Alekseev VK, Uvarov NA, Karbusheva EYu. Lekarstvennye formy s modifitsirovannym vysvobozhdeniem na osnove pellet. Farmatsiya. 2012;4:51-4.Russian.
2. Developing lipid based formulations for oral bioavailability enhancement // Formulation guidelines. Version (2) 2010., Developing lipid based formulations for oral bioavailability enhancement. Formulation guidelines. 2010;2.
3. Fatouros D.G., Karpf D.M., Nielsen F.S., Mullertz A. Clinical Studies with Oral Lipid Based Formulations of Poorly Soluble Compounds // Therapeutics And Clinical Risk Management. 2007. Vuol. 3. №4. С. 591-604., Fatouros DG, Karpf DM, Nielsen FS, Mullertz A. Clinical Studies with Oral Lipid Based Formulations of Poorly Soluble Compounds. Therapeutics And Clinical Risk Management. 2007;3(4):591-604.
4. Patro M.N. Oral lipid based formulation: a review // International Journal of Pharma and Bio Sciences V1(2) 2010., Patro MN. Oral lipid based formulation: a review. International Journal of Pharma and Bio Sciences. 2010;1(2).
5. Reddy M. Sunitha Solubility enhancement of fenofibrate, a BCS class II drug, by self emulsifying drug delivery systems // IRJP. 2011. №2(11). Р. 173-177., Reddy M. Sunitha Solubility enhancement of fenofibrate, a BCS class II drug, by self emulsifying drug delivery systems. IRJP. 2011;2(11):173-77.